MapLight Therapeutics
Creating breakthrough innovative therapeutics for serious CNS disorders
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2018
- Business Model
- Other
- Website
- maplighttx.com
- Total Funding
- $372.5M
- Last Round
- $372.5M Series DJul 2025
About
MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics for central nervous system (CNS) disorders using an integrated computational and experimental platform.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account